Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05PHH
|
|||
| Former ID |
DNC000671
|
|||
| Drug Name |
Gabexate
|
|||
| Synonyms |
gabexate; Gabexate [INN]; 39492-01-8; Gabexatum [INN-Latin]; Gabexato [INN-Spanish]; UNII-4V7M9137X9; CHEMBL87563; C16H23N3O4; Gabexate (INN); 4V7M9137X9; Ethyl p-hydroxybenzoate 6-guanidinohexanoate; ethyl 4-[6-(diaminomethylideneamino)hexanoyloxy]benzoate; Gabexatum; Gabexato; Benzoic acid, 4-((6-((aminoiminomethyl)amino)-1-oxohexyl)oxy)-, ethyl ester; p-carbethoxyphenyl e-guanidinocaproate; AC1L1FYH; Prestwick3_001008; Prestwick2_001008; Prestwick0_001008; Prestwick1_001008; BSPBio_001135; SCHEMBL446024; SPBio_003016; GTPL7863
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Pancreatitis [ICD-11: DC31-DC34] | Approved | [1], [2] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H23N3O4
|
|||
| Canonical SMILES |
CCOC(=O)C1=CC=C(C=C1)OC(=O)CCCCCN=C(N)N
|
|||
| InChI |
1S/C16H23N3O4/c1-2-22-15(21)12-7-9-13(10-8-12)23-14(20)6-4-3-5-11-19-16(17)18/h7-10H,2-6,11H2,1H3,(H4,17,18,19)
|
|||
| InChIKey |
YKGYIDJEEQRWQH-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 39492-01-8
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
5651497, 11114218, 11467036, 11468156, 11486752, 14777053, 29222581, 47515431, 47662419, 48110567, 48334621, 49699245, 50064760, 50104958, 50421296, 56198476, 57321805, 85788084, 96024697, 103292587, 103843945, 104000374, 104303542, 117573813, 126407608, 129807876, 135001838, 140836832, 142058254, 164814489, 179148578, 179322524, 198945816, 223366193, 226767900, 238285244, 251916822, 251918061, 252359390
|
|||
| ChEBI ID |
CHEBI:93036
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Serine protease unspecific (SP) | Target Info | Inhibitor | [3] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7863). | |||
| REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 3 | Tryptase-positive mast cells correlate with angiogenesis in early breast cancer patients. Int J Oncol. 2009 Jul;35(1):115-20. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.